![Medtronic PROTECTA XT DR D314DRG Скачать руководство пользователя страница 161](http://html.mh-extra.com/html/medtronic/protecta-xt-dr-d314drg/protecta-xt-dr-d314drg_clinician-manual_1763148161.webp)
6.7 Monitoring for thoracic fluid accumulation with OptiVol
Clinical studies have shown that lung congestion is a primary complication associated with
heart failure and is a frequent cause of repeated hospital admissions.
Patients with moderate to severe heart failure are at risk of further cardiac decompensation
as a result of total body and thoracic fluid accumulation. Early detection of thoracic fluid
accumulation may enable more timely treatment adjustments.
6.7.1 System solution: OptiVol 2.0 Fluid Status Monitoring
Clinical data suggest that changes in thoracic impedance and fluid accumulation in the
thoracic cavity or lungs are inversely correlated.
As the patient’s lungs become congested,
thoracic impedance tends to decrease. Similarly, an increase in thoracic impedance may
indicate the patient’s lungs are becoming drier.
The OptiVol 2.0 Fluid Status Monitoring feature measures the patient’s thoracic impedance
using the RVcoil to Can pathway, which passes through the tissue within the thoracic cavity.
Increases in thoracic fluid cause a decrease in impedance for this pathway. Decreases in
thoracic fluid cause an increase in impedance for this pathway.
Notes:
●
The OptiVol Fluid Status Monitoring feature has been updated to OptiVol 2.0 to account
for individual patient variation, including allowing the Fluid Index to increase or decrease
based on recent thoracic impedance measurements.
●
The OptiVol 2.0 Fluid Status Monitoring feature may not provide early warning for all
fluid-related decompensations. Therefore, patients should be instructed to seek
medical attention immediately any time they feel ill and need help, even if the OptiVol
fluid monitoring features of their device or monitor indicate acceptable pulmonary fluid
status conditions.
●
The OptiVol 2.0 Fluid Status Monitoring feature is an additional source of information
for patient management and does not replace assessments that are part of standard
clinical practice.
●
The clinical value of the OptiVol 2.0 Fluid Status monitoring feature has not been
assessed in those patients who do not have fluid retention related symptoms due to
heart failure.
5
Bennett SJ, et al. Characterization of the precipitants of hospitalization for heart failure
decompensation. American Journal of Critical Care. 1998; 7:168–174.
6
Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure. Circulation.
2005; 112:841–848.
Medtronic
PROTECTA™ XT DR D314DRG
Clinician Manual
161
Содержание PROTECTA XT DR D314DRG
Страница 2: ......
Страница 9: ...Index 488 Medtronic PROTECTA XT DR D314DRG Clinician Manual 9 ...
Страница 506: ......
Страница 507: ......